awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38927992-477BA962-8691-4E93-BD37-73A2A70F0CA2
Q38927992-477BA962-8691-4E93-BD37-73A2A70F0CA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38927992-477BA962-8691-4E93-BD37-73A2A70F0CA2
Activity of erlotinib when dosed below the maximum tolerated dose for EGFR-mutant lung cancer: Implications for targeted therapy development.
P2860
Q38927992-477BA962-8691-4E93-BD37-73A2A70F0CA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38927992-477BA962-8691-4E93-BD37-73A2A70F0CA2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ec83d15b584da3c525cf37a02db505f85c2a372
P2860
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.